MARKET

IDXG

IDXG

Interpace
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8051
-0.0104
-1.28%
Opening 14:23 10/14 EDT
OPEN
0.8155
PREV CLOSE
0.8155
HIGH
0.8334
LOW
0.8020
VOLUME
48.12K
TURNOVER
--
52 WEEK HIGH
1.550
52 WEEK LOW
0.6727
MARKET CAP
35.84M
P/E (TTM)
-1.5633
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IDXG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IDXG News

  • 18 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.09/30 12:45
  • Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans
  • GlobeNewswire.09/30 11:55
  • Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans Giving 5M People Access to Thyroid Assays
  • Benzinga.09/30 10:56
  • Benzinga's Top Upgrades, Downgrades For September 26, 2019
  • Benzinga.09/26 13:40

More

Industry

Business Support Services
+0.02%
Professional & Commercial Services
-0.13%

Hot Stocks

Name
Price
%Change

About IDXG

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
More

Webull offers Interpace Diagnostics Group Inc (IDXG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.